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The neuroectodermal tissue close to the midbrain–hindbrain boundary (MHB) is an important secondary organizer in the developing neural
tube. This so-called isthmic organizer (IsO) secretes signaling molecules, such as fibroblast growth factors (FGFs), which regulate cellular
survival, patterning and proliferation in the midbrain and rhombomere 1 (R1) of the hindbrain. We have previously shown that FGF-receptor 1
(FGFR1) is required for the normal development of this brain region in the mouse embryo. Here, we have compared the gene expression profiles
of midbrain–R1 tissues from wild-type embryos and conditional Fgfr1 mutants, in which FGFR1 is inactivated in the midbrain and R1. Loss of
Fgfr1 results in the downregulation of several genes expressed close to the midbrain–hindbrain boundary and in the disappearance of gene
expression gradients in the midbrain and anterior hindbrain. Our screen identified several previously uncharacterized genes which may participate
in the development of midbrain–R1 region. Our results also show altered neurogenesis in the midbrain and R1 of the Fgfr1 mutants. Interestingly,
the neuronal progenitors in midbrain and R1 show different responses to the loss of signaling through FGFR1.
© 2006 Elsevier Inc. All rights reserved.Keywords: FGFR1; Isthmic organizer; Midbrain; Hindbrain; Neuronal progenitors; Proliferation; Midbrain dopaminergic neurons; Raphe nuclei; Locus coeruleus;
MicroarrayIntroduction
Isthmic organizer (IsO) acts as an signaling center that
regulates the development of the midbrain and rhombomere 1
(R1) by secreted molecules, such as fibroblast growth factors
(FGFs) FGF8/17/18 and WNT1 (reviewed in Echevarria et al.,
2003; Liu and Joyner, 2001; Nakamura, 2001; Wurst and Bally-
Cuif, 2001). These signals are thought to regulate cellular
survival, proliferation and differentiation in the developing mid-
and hindbrain.
Where the expression of two homeobox transcription factors
Otx2 and Gbx2 abuts defines the position of the midbrain–
hindbrain boundary (MHB) and IsO (Broccoli et al., 1999;⁎ Corresponding author. Fax: +358 9 191 59366.
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doi:10.1016/j.ydbio.2006.05.002Katahira et al., 2000; Millet et al., 1999). MHB also coincides
with the boundary of cell-lineage restriction (Zervas et al.,
2004). Expression of IsO signal Wnt1 gets restricted to the
caudal midbrain and Fgf8 to the rostral R1 (Li and Joyner,
2001). The early development of midbrain–hindbrain region
requires both WNT1 and FGF8. In Wnt1 null mutant and Fgf8
midbrain–R1 mutant embryos, cells in the midbrain and R1 die
apoptotically around E8.5 (Chi et al., 2003; McMahon and
Bradley, 1990; Thomas and Capecchi, 1990).
In addition to cell survival, IsO also appears to regulate
precursor cell proliferation in the MHB region. Studies in
zebrafish and mouse have indicated that cells in the posterior
midbrain and anterior R1 express basic helix–loop–helix
transcription factors belonging to Hairy/E(spl) family and
undergo neuronal differentiation later than the cells further
away from the IsO (Geling et al., 2003; Hirata et al., 2001;
Ninkovic et al., 2005). Lineage tracing studies in zebrafish
142 T. Jukkola et al. / Developmental Biology 297 (2006) 141–157suggest that these progenitor cells contribute to the structures
of midbrain and anterior hindbrain (Tallafuss and Bally-Cuif,
2003). In the mouse, premature differentiation of neuronal
precursors is prevented by transcription factors Hes1 and
Hes3 (Hirata et al., 2001). These genes also maintain the
expression of isthmus specific genes, such as Pax2/5, Fgf8
and Wnt1. Later, FGF8 and FGF17 also redundantly
participate in keeping the cells of dorsal R1 in a proliferative
state thus inhibiting neuronal differentiation in the vermis
primordium (Xu et al., 2000). The control of cellular
proliferation is also involved in the development of a coherent
boundary cell population at the midbrain–hindbrain border.
We have previously characterized a slowly proliferating
narrow boundary cell population which is located on either
side of the MHB (Trokovic et al., 2005). These FGFR1-
dependent cells express specific cell cycle regulators and cell-
adhesion molecules and are needed for the development of the
isthmic constriction. Compared to Hes3, Fgf8 or Wnt1
positive cells, this boundary cell population is much narrower
in the A–P dimension and includes only a subset of these
cells.
IsO also regulates differentiation of brain structures and
nuclei in the midbrain and R1. In ventral midbrain, nuclei
including dopaminergic (DA) neurons of the substantia nigra
(SN) and ventral tegmental area (VTA) develop. By contrast,
serotonergic neurons (SA) develop in the ventral hindbrain,
and noradrenergic (NA) neurons of locus coeruleus (LC) and
nucleus subcoeruleus (NSC) will form in the dorsal R1. The
location and the size of the colliculi, cerebellum as well as
DA, SA and NA cell populations is determined by the
position of the IsO (Brodski et al., 2003; Lam et al., 2003;
Prakash et al., 2006; Andersson et al., 2006). According to
the current view, the development of DA and SA neurons is
induced by both SHH from the floor plate and FGF8 from the
isthmus (Ye et al., 1998). Other factors, such as TGF-βs are
also needed for the induction and maintenance of midbrain
DA neurons (Farkas et al., 2003). In addition to FGF8
signals, FGF4 is needed for SA neuron induction in vitro
cultured R1 explants, but its role in vivo has not been
demonstrated (Ye et al., 1998). Inductive signals in the
specification of LC include BMPs from the roof plate and
FGF8 from the isthmus (Lam et al., 2003).
Four FGF receptors (FGFR1–4) have been identified in
vertebrates. Fgfr1–3 are expressed during the early brain
development in the mouse (Blak et al., 2005; Liu et al.,
2003; Trokovic et al., 2005; Walshe and Mason, 2000). Our
earlier results have shown that FGFR1 is required for the
development of anterior hindbrain and posterior midbrain
(Trokovic et al., 2003). Fgfr1 conditional knock out mice,
where FGFR1 has been inactivated in the midbrain and R1
at E8.5, lack vermis of the cerebellum and inferior colliculi.
Ventrally, the major neuronal subtypes are present, but
appear disorganized. The phenotype of the conditional Fgfr1
mutants is much less severe than the phenotype of
conditional Fgf8 mutants produced by a similar approach
(Chi et al., 2003). In contrast to Fgf8 mutants, the phenotype
observed in Fgfr1 mutant mice is not due to the apoptosis inthe early MHB tissue. Instead, the loss of Fgfr1 leads to a
failure to establish a coherent midbrain–hindbrain boundary
and maintain IsO specific gene-expression after E9.5
(Trokovic et al., 2003, 2005). Fgfr2 and Fgfr3 expression
diminishes towards the MHB. However, they are still
expressed in the midbrain–R1 region, especially in the
ventral part where they may contribute to IsO signaling
(Blak et al., 2005; Trokovic et al., 2005).
In this study, we further define the molecular and cellular
defects in Fgfr1 conditional mutant embryos. To identify
genes, which are expressed at the midbrain–R1 region, we
have compared gene-expression profiles of E10.5 wild-type
and conditional Fgfr1 mutant embryos. In our screen, we have
identified several new genes that may be involved in the
development of the midbrain and anterior hindbrain. Observed
changes in gene expressions suggest alterations in the
maintenance of the neuronal progenitors on both sides of the
MHB. Surprisingly, midbrain DA and hindbrain SA neuron
progenitor populations appear to have different requirements
for signaling through FGFR1.
Material and methods
Mice and genotyping
En1-Cre (Kimmel et al., 2000) and Fgfr1Flox (Trokovic et al., 2005) alleles
have been described previously. Mutant embryos were generated by crossing
En1-Cre/+; Fgfr1Flox/+males with Fgfr1Flox/Flox females in outbred (129sv/ICR)
background. Follistatin mutant mice and their genotyping has been described
earlier (Matzuk et al., 1995). Embryonic age (E) was estimated by counting the
somites or considering noon of the day of a vaginal plug as E0.5. For genotyping
of the mice and embryos, see Trokovic et al. (2003). All the experiments were
approved by the committee of experimental animal research of the University of
Helsinki.
Microarray analysis
Tissue containing posterior midbrain and anterior rhombomere 1 of E10.5
wild-type and Fgfr1 mutant embryos was dissected (Supplementary Fig. 1 to
show approximate area). Individual tissues were snap frozen in liquid nitrogen
and pooled after the genotype was confirmed (5–6 tissue samples/pool). Tissues
were lysed in pooled groups (2 wild-type pools, 2 mutant pools) and total RNA
was extracted from the tissue lysate using Trizol reagent (Invitrogen) and
RNeasy kit (Qiagen) clean-up procedure. Approximately 5 μg of total RNA
from each of the four independent samples was processed to produce
biotinylated cRNA targets, which were hybridized to Affymetrix Genechip
mouse U74Aversion 2 arrays following standard Affymetrix procedures (http://
www.affymetrix.com).
12 arrays were used and each demonstrated control parameters within
recommended limits (Raw Q < 30, background < 85, GAPDH 3′/5′ ratios below
1.5). To allow comparison between U74A arrays, each was analyzed using
global scaling with a target intensity of 300. The scaling factors used to
normalize to the target value were within 4-fold of each other in all comparisons
(A chip: 0.683 to 1.226; B chip 1.597 to 3.782; C chip: 1.612 to 4.027).
Affymetrix Microarray Suite version 5.0 (MAS 5.0) software was used to make
each pairwise comparison between the two wild-type and the two mutant arrays.
MAS 5.0 data were then exported to Lotus Notes database, in which the ‘Signal
Log Ratios’were converted to fold changes. Using the default MAS 5.0 settings,
a probe set with a detection P value less than 0.05 were considered present. Only
transcripts called as present (detection P value < 0.05) in at least one wild-type
sample, and showing a 0.74-fold or smaller and 1.41-fold or greater difference
(change P value for up-regulated genes 0 to 0.0025; down-regulated genes 0.997
to 1) between the wild-type and mutant MHB samples in at least 3 out of the 4
comparisons were included. We chose 0.75-fold change as our empirical cut-off
Table 1











Fgf17 98730_at 0.06 Fig. 1B Xu et al. (2000)
Spry1 163956_at 0.24 Fig. 1C Zhang et al.
(2001)
En1 96523_at 0.29 Fig. 2A Davis and
Joyner (1988)
Fgf8 97742_s_at 0.30 Fig. 1B Crossley and
Martin (1995)
Spry2 116938_at 0.30 Fig. 1C Zhang et al.
(2001)
Trh 102665_at 0.31 Fig. 2E IMAGE 559851
Cnpy1 138472_at 0.35 Fig. 2C AI853839 (3′)
IMAGE:6390940
(5′)
Fgf18 95316_at 0.35 Fig. 1B Xu et al. (2000)




Tnfrsf19 (Trade) 160670_at 0.39 Fig. 2K Pispa et al.
(2003)
Sef 133830_at 0.41 Fig. 1C IMAGE 1178421
Erm (Etv5) 163173_at 0.41 Fig. 1D IMAGE 3674281
Mkp3 (Dusp6) 93285_at 0.42 Fig. 1C IMAGE 874051
Nfia 130461_at 0.48 –
Mrp4 (Abcc4) 111137_at 0.50 Fig. 2F IMAGE 1153158
Pax5 95890_r_at 0.50 Fig. 2D IMAGE 3333164
EST6 163120_at 0.51 –
Pcx 171076_i_at 0.51 –
En2 98338_at 0.52 Fig. 2B Liu and Joyner
(2001)
Sfrp2 93503_at 0.52 Fig. 2L IMAGE 4487469
Fgf15 97721_at 0.54 Fig. 1B McWhirter et al.
(1997)
Atp1a1 93797_g_at 0.54 –
4921506J03Rik 99163_at 0.54 –
Igfbp5 100566_at 0.54 Fig. 2J IMAGE 318625
Nfib 160859_s_at 0.54 –
RhoA (Arha2) 101112_g_at 0.55 –
Sox3 92264_at 0.56 Fig. 2I IMAGE 368804
Drapc1 96132_at 0.59 Fig. 2M Jukkola et al.
(2004)
Flrt3 110370_at 0.60 Fig. 1C IMAGE 5702881
Epcs3 (Ftsj3) 95756_at 0.60 –
Ccnd2 97504_at 0.60 Fig. 2H IMAGE 367058
Fabp7 98967_at 0.62 –
Eef1a1 94766_at 0.63 –
Pip92 (Ier2) 99109_at 0.63 Data not
shown
Pea3 (Etv4) 92979_at 0.64 Fig. 1D Lin et al. (1998)
Kik1 (Hsd17b12) 94276_at 0.65 –
Snx5 117186_at 0.65 –
Tcf7 97994_at 0.65 Fig. 2N A gift from Irma
Thesleff
Bnip3l 96255_at 0.66 –
Gstm5 100629_at 0.67 –
Prkrir 99975_at 0.67 –
Ccnb1 160159_at 0.69 Data not
shown
Spred2 161070_at 0.69 –
Nrp 95016_at 0.69 –
Rraga 94257_at 0.70 –
1200007D18Rik 160184_at 0.71 –
















Sox21 167903_at 0.72 Data not
shown
D7Wsu128e 103861_s_at 0.74 –
Jmj 94341_at 0.74 Fig. 2G IMAGE 6406875
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situ hybridization. Corresponding cut-off value for up-regulated genes was 1.41-
fold. The data were sorted by average fold-change to produce the two lists of
gene expression levels shown in Tables 1 and 2. This filtering of the data means
that some genes with spatially and temporally restricted patterns may be
excluded. Especially this is likely to be the case for genes with low expression
levels.
In situ hybridization analyses
Whole mount mRNA in situ hybridization analyses of E9.5–E11.5 day
embryos (n≥3) were performed as described (Henrique et al., 1995).
Digoxigenin (DIG) -labeled antisense and sense RNA probes were synthesized
from linearized plasmid DNAs using DIG-labeling mix (Roche) and T3, T7 and
SP6 RNA polymerases. After whole-mount staining, some of the embryos were
dehydrated, embedded in paraffin and sectioned coronally at 10 μm. Sections
were counterstained with nuclear red (Vector). Radioactive in situ hybridization
on 5 μm sagittal sections was done according to Wilkinson and Green (1990)
using 35S labeled RNA probes. Plasmids used for validating microarray results
are listed in Tables 1 and 2. Other probes used for in situ analysis were Ngn2
(IMAGE 2922473), Phox2a (IMAGE 534970), Pitx3 (IMAGE 482871), Pet1
(clone UI-M-BH3-avj-b-02-0-UI.s1), Nurr1 (Wallen et al., 1999), GATA3
(Lillevali et al., 2004),Mash1 (IMAGE 6415061), Hes3 (clone UI-R-BO1-ajt-e-
02-0-UI.r1), Aldh1 (Hermanson et al., 2003), and Otx2 (Acampora et al., 1997).Table 2









Probe for in situ
hybridisation
Fst 98817_at 4.00 Fig. 3M, N Wang et al. (2004)
EST 166028_s_at 2.22 –
Tal-2 129118_at 2.00 –
Mab21l1 165815_r_at 1.89 Fig. 3F IMAGE 4526962
Ednrb 163124_s_at 1.87 Fig. 3I IMAGE 4971909
Math1 168404_at 1.84 Fig. 3D IMAGE 4218223
EST 113895_at 1.77 –
Rgma 108717_at 1.66 Fig. 3C IMAGE 1001290
EST 139205_at 1.66 Fig. 3K IMAGE 2655939
Vtn 98459_at 1.65 Fig. 3A IMAGE 5366291
Uncx4.1 92499_at 1.60 Fig. 3H IMAGE 5716567
Ngfr (p75) 108762_at 1.57 Fig. 3G Qun et al. (1999)
EST 137358_at 1.55 Fig. 3L IMAGE 3329477
Maf 115390_at 1.52 –
EST 167322_at 1.52 –
Ckb 137242_f_at 1.49 Supp. Fig. 7J IMAGE 6395794
Pltp 100927_at 1.46 Data not shown IMAGE 4979759
Nhlh2 166814_f_at 1.44 –
EST 166871_at 1.44 Fig. 3J IMAGE 3823589
Wfdc1 166414_at 1.43 Fig. 3B IMAGE 1497229
Tcpn1 10851 5_at 1.41 – IMAGE 653006
Dach1 114999_at 1.41 Fig. 3E IMAGE 6826750
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The antibodies used for immunohistochemistry on paraffin sections were
anti-5-HT antibody (1:5000; Immunostar) for E15.5 serotonergic neurons, anti-
5-HT (1:2000, MPBiomedicals Cappel) for adult serotonergic neurons, anti-TH
antibody (1:500; Chemicon international) for dopaminergic and noradrenergic
neurons and anti-Tuj1 antibody (1:300; Covance). Secondary antibodies used
were anti-rabbit-IgG (1:300; Alexa-488, Molecular Probes) and anti-mouse-IgG
(1:300; Alexa-488, Molecular Probes).
For quantification of the dopaminergic and serotonergic neurons, embryos
(3 mutant and 3 wild-type embryos) were fixed for 1 week in 4% PFA at +4°C,
dehydrated and embedded in paraffin. Embryos were sectioned sagittally at
5 μm. After deparaffination, the antigen retrieval was done by heating the
sections in 10 mM sodium-citrate buffer, pH 6.0, in a microwave oven. The
sections were washed in PBS and blocked for 30–60 min in PBT (PBS + 1%
BSA + 10% goat serum + 0.3% Triton-X). The samples were incubated in the
primary antibody in PBT over 3 nights at +4°C, rinsed in PBS and placed in the
secondary antibody in PBT for 3 h at RT. Sections were rinsed twice in PBS and
once in sterile water before mounting them in Vectashield with DAPI (Vector).
Immunostaining was visualized with an Olympus AX70 microscope with
Olympus DP70 camera.
Quantification
For E15.5 serotonergic neurons, only cell populations in rostral hindbrain
were counted. To simplify the comparison between the samples, the results were
combined into two populations: dorsal and ventral serotonergic neurons. Since
the distance between two analyzed sections was always 50 μm and the diameter
of one positive cell was estimated to be 12–15 μm, the number of cell layers
between two sections was approximated to be 4. Total number of positive cells
detected in each population was then multiplied by the number of cell layers to
get the total amount of positive cells in the whole region.
For dopaminergic neurons, the positive cells in ventral tegmental area and
substantia nigra were counted and the results divided into two populations:
caudal (c) and rostral (r) dopaminergic neurons. The location of the most caudal
DA neurons in the wild-type embryos determined the border between r- and c -
sectors. The caudal boundary of the DA neurons in mutant embryos was used to
draw the caudal boundary of the c-sector. The rostral sector was drawn around
all ventral DA neurons located rostrally to r–c boundary.
Student's t test was used for the comparison of the mean values, and sample
variance was compared using Levene's test. For quantification of adult 5-HT
neurons, brains were sectioned horizontally and 5-HT immunohistochemistry
was performed according to Brodski et al. (2003). The number of 5-HT positive
cells was determined using Stereoinvestigator software (MBF Bioscience).Results and discussion
To address the role of FGF signaling and its gene
expression networks in the mouse midbrain–R1 region we
compared the gene expression profiles of wild-type embryos
and embryos carrying a tissue-specific inactivation of the
Fgfr1 gene in the neuroectoderm of midbrain and R1 (En1-
Cre/+; Fgfr1Flox/Flox; Trokovic et al., 2003). For this, we
dissected the midbrain–R1 tissues from E10.5 wild-type and
conditional Fgfr1 mutant mice. Stage E10.5 was selected for
the analysis because a large set of genes was expected to
change their expression in the mutants by this stage. These
genes would include both direct and indirect targets of FGF
signaling. All the direct targets, presumably affected already at
an earlier time point, would be expected to be found among the
up- or downregulated genes also at E10.5. In addition, larger
amount of tissue available at E10.5 allowed probe preparation
without an amplification step. Individual midbrain–R1 tissues(n = 6) were pooled after the genotype was confirmed. The
gene expression levels of wild-type (n = 2) and Fgfr1 mutant
(n = 2) tissue sample pools were analyzed by Affymetrix
microarrays (see Materials and methods and Supplementary
Fig. 1 for detailed description). Data analysis of gene
expression levels between duplicate wild-type and mutant
tissue pools revealed that 75% of sequences on the array were
identified as present. Comparison of the four data sets (2 wild-
type control vs. 2 Fgfr1 mutant samples) with <0.75-fold or
>1.41-fold difference thresholds in at least 3 out of 4
independent comparisons, identified 51 down-regulated and
20 up-regulated genes, respectively. The lists of differentially
expressed genes are shown in Tables 1 and 2.
Microarray analysis was followed by whole-mount mRNA
in situ hybridization to confirm the pattern of expression of a set
of differentially expressed genes. Expression of 25 out of 51
down-regulated and 15 out of 20 up-regulated genes was
analyzed by in situ hybridization. In addition, real-time relative
RT-PCR assay showed similar abundance values for four genes
that were differentially expressed in microarray analysis (Fgf17,
Igfbp5, Follistatin and Wfdc1, data not shown).
Down-regulated genes
Components of the FGF signal transduction pathway
The down-regulated genes included several known members
of the FGF signal transduction pathway (Fig. 1A). These
included FGF ligands, signal regulators and nuclear effectors.
Fgf family members Fgf8, Fgf15, Fgf17, and Fgf18 are
expressed in the midbrain–R1 region. Comparison of gene
expression levels by microarray analysis showed that all these
Fgfs were down-regulated in E10.5 Fgfr1 mutant mice (Table
1). This was confirmed by in situ hybridization analysis of
E10.5 embryos (Fig. 1B). In Fgfr1 mutants, Fgf17 mRNAwas
completely abolished from the midbrain–R1 region. In contrast,
Fgf8 was abolished from the dorsal part of the anterior R1, but
remained in a small ventral patch (Fig. 1B, red arrow;
Supplementary Fig. 2). Similarly to Fgf17, down-regulation
of Fgf18 expression was observed in the midbrain–R1 region in
the Fgfr1 mutant embryos. Expression of Fgf15 was decreased
especially in the alar plate of the midbrain–R1 region of the
Fgfr1 mutants (Fig. 1B, Supplementary Fig. 2).
Members of the Sprouty, SEF (similar expression to Fgfs),
and mitogen-activated protein kinase phosphatase (MKP)
families are negative modulators of FGF signaling, whereas
nuclear targets of FGF signaling include the ETS transcription
factors Erm and Pea3. These molecules affect the FGF
signaling cascade at different levels to regulate the final output
of the FGFR mediated signal transduction (Fig. 1A).
SEF, Sprouty proteins (SPRY1-5), and MKP3 act as negative
regulators of the FGF/Ras–MAPK–ERK signaling pathway
(Furthauer et al., 2002;Mason et al., 2004;Minowada et al., 1999;
Tsang et al., 2002; Yusoff et al., 2002). In the Fgfr1 mutant
embryos, Sef and Spry1 transcripts were abolished from the dorsal
midbrain–R1 domain, but remained in the ventral midbrain–R1
region (Fig. 1C, dotted line; Supplementary Fig. 2). By contrast,
expression of Spry2 and Mkp3 was down-regulated throughout
Fig. 1. Expression patterns of FGFR1 signaling cascade components at E10.5. Scheme of the FGF signal transduction pathway (A). Whole mount in situ hybridization
of wild-type and En1-Cre/+;Fgfr1Flox/Flox mutant embryos show altered gene expression of known FGF signaling components at E10.5 (B–D). Lateral views of the
whole-mount-stained embryos, anterior rightwards. The MHB is marked with arrowheads and a dotted line. Ventral midbrain–R1 region is marked with a red broken
line. Down-regulation of different FGF genes (B). At E10.5, expression of Fgf17/8/18/15 in the dorsal midbrain and R1 was clearly down-regulated, but some
expression was maintained in the ventral domain (arrows in B, see also Supplementary Fig. 2). Molecules that are known to be associated with FGF signal transduction
(C) and proximal downstream targets of FGF signaling (D) were also down-regulated in Fgfr1 mutant embryos.
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compared to wild-type embryos (Fig. 1C). Earlier expression
studies have shown that Mkp3 expression is co-localized with
Fgf8 also near theMHB (Dickinson et al., 2002; Echevarria et al.,
2005; Klock and Herrmann, 2002). Mkp3 expression was
gradually down-regulated in the Fgfr1 mutant embryos starting
from E9.0 (20 somite stage) (Supplementary Fig. 2).
The FLRT family of proteins structurally resembles small
leucine-rich proteoglycans found in the extracellular matrix and
are thought to promote FGF signaling. Recent studies showed
that rat and Xenopus Flrt3 genes are coexpressed with Fgfs and
are regulated by FGF signaling (Bottcher et al., 2004; Lacy et
al., 1999; Robinson et al., 2004). At E10.5, expression of Flrt3
in wild-type embryos was detected at the MHB region, both in
midbrain and R1 (Fig. 1C, Supplementary Fig. 5). In the Fgfr1
mutant embryos, Flrt3 expression domain at the MHB region
was abolished.
Pea3 and Erm are members of ETS family transcription
factors and thought to be proximal transcriptional targets of
FGF signaling (Chotteau-Lelievre et al., 2001; Monte et al.,
1994). At E10.5, expression of Erm and Pea3 was clearly
down-regulated in the midbrain–R1 region in the Fgfr1
mutant embryos compared to the wild-type (Fig. 1D).
However, in Fgfr1 mutants, some expression of Erm and
Pea3 was still detected in the ventral region (Supplementary
Fig. 2), indicating the presence of residual FGF signaling.
Thus, validating our microarray approach, many known
members of the FGF synexpression group and components of
the FGF signal pathway were identified as being down-
regulated in the conditional Fgfr1 mutants.
Other down-regulated genes
We also found several other genes being downregulated in
Fgfr1 mutants. These include genes involved in the patterning
of midbrain and R1, MHB-specific genes, cell-cycle regulators,
and components of various signal transduction cascades.
Expression of IsO regulated transcription factors En1/2 and
Pax5was abolished at the dorsal part of the midbrain–R1 region
of mutant embryos (Figs. 2A′, B′, D′). Interestingly, previously
uncharacterized gene (NM_175651; Affymetrix probe ID:
138472_at) showed similar expression pattern to the En2 gene
(Figs. 2C, C′). The zebrafish ortholog was recently named as
Canopy1 (Cnpy1, NM_001039497) and its inactivation by
antisense morpholinos resulted in midbrain–R1 defects (Hirate
and Okamoto, 2006). Physically, mouse Cnpy1 gene is located
32 kb downstream of En2 locus in chromosome 5, but it is
transcribed from the opposite strand (see detailed description in
Supplementary Fig. 3).
Genes expressed as a narrow stripe near the MHB include
Trh, Mrp4, Igfbp5 and Jumonji (Jmj). Thyrotropin-releasing
hormone (TRH), originally isolated as a hypothalamic
neuropeptide hormone, most likely acts also as a neuromodu-
lator and/or neurotransmitter in the central nervous system
(Urayama et al., 2002; Yamada et al., 1997). We detected
strong expression of Trh in the neuroepithelium of prospective
brain already at E8.0 and at E10.5, expression of Trh was
detected in a narrow band near the MHB in wild-type embryos(Supplementary Fig. 4; Fig. 2E). Section in situ analysis
showed that Trh expression was localized to the Otx2 positive
cells near the MHB (Supplementary Fig. 5). In the Fgfr1
mutant embryos, Trh expression was strongly down-regulated
(Fig. 2E′). Interestingly, TRH knockout mice showed de-
creased expression of cell cycle regulator PF-TAIRE in the
cerebellum (Hashida et al., 2002). Although no obvious CNS
defects were detected in adult mice, detailed analysis of the
role of Trh in the early brain development has not been
performed. MRP4 (or ABCC4) belongs to the ABC transporter
molecules and is further grouped to the multidrug resistance
related protein (MRP) subfamily. We found that Mrp4
expression was restricted to a region near the MHB at E9.5–
E10.5 (Fig. 2F; Supplementary Fig. 4). At E10.5, Mrp4
expression was detected in the most anterior R1 (Supplemen-
tary Fig. 5). Weaker expression was also detected in the
olfactory bulb and eye primordium (Supplementary Fig. 4). In
the Fgfr1 mutant embryos, Mrp4 expression was abolished
from the midbrain–R1 region (Fig. 2F′). At E10.5, expression
of Igfbp5 was localized in distinct cell populations on both
sides of the MHB (Fig. 2J, Supplementary Fig. 5). In Fgfr1
mutants, Igfbp5-positive cells were not detected at the border
between mid- and hindbrain (Fig. 2J′). By contrast, in the
dorsal R1 Igfbp5 expression domain was expanded rostrally
(red arrowheads in Fig. 2J′). Jumonji can function as a
transcriptional repressor of CyclinD1, D2, and cdc2 (Jung et
al., 2005; Takahashi et al., 2004; Toyoda et al., 2003). At
E10.5, we observed Jmj expression as a narrow stripe close to
the MHB in the wild-type embryos (Fig. 2G), but Fgfr1 mutant
embryos lack most of the Jmj expression (Fig. 2G′). Together,
these results demonstrate both similarities and differences in
the gene-expression in the slowly proliferating boundary cells
in the posterior midbrain and the most anterior R1 (Trokovic et
al., 2005).
D-type cyclins promote cell cycle progression under the
control of extracellular signals such as FGFs or WNTs. At
E10.5, CyclinD2 was broadly expressed in the dorsal midbrain
and hindbrain (Fig. 2H), but a narrow domain of CyclinD2-
negative cells were detected in the border between mid- and
hindbrain (Trokovic et al., 2005). In the Fgfr1 mutant embryos,
the overall CyclinD2 expression level was reduced both in
the midbrain and R1 and the negative CyclinD2 domain
between midbrain and R1 was abolished (Fig. 2H′). Jmj
expression (see above) might repress CyclinD2 levels near the
MHB leading to decreased cell cycle progression of the
boundary cell population.
Sox3 is broadly expressed throughout the developing neural
tube. In the wild-type E10.5 controls, Sox3 expression was
detected broadly in the CNS (Fig. 2I). Similarly to CyclinD2,
Sox3-positive cells were not seen in the narrow population of
cells between mid- and hindbrain. In Fgfr1 mutants, Sox3-
negative domain near the MHB was abolished (Fig. 2I′), but
the overall signal was weaker in the midbrain–R1 region (Fig.
2I′, red bracket). Recent study by Rizzoti et al. (2004) has
shown that cells lacking SOX3 are not able to maintain
endogenous cell proliferation in the ventral diencephalon
leading to abnormal development of Rathke's pouch. Thus,
Fig. 2. Expression patterns of other down-regulated genes detected by the microarray screen. Whole mount in situ hybridization of the indicated genes at E10.5.
Analysis confirmed the down-regulation of genes in the midbrain–hindbrain region of the En1-Cre/+;Fgfr1Flox/Flox embryos. Lateral views of the whole-mount-stained
wild-type (A–N) and Fgfr1 mutant (A′–N′) embryos (anterior rightwards). The MHB is marked with a white arrowhead. Red arrows in K′, L, L′, and M′ indicate
altered gene expression. di, diencephalon; te, telencephalon.
147T. Jukkola et al. / Developmental Biology 297 (2006) 141–157
148 T. Jukkola et al. / Developmental Biology 297 (2006) 141–157SOX3 activity might be necessary to maintain normal rates
of proliferation in the neuroepithelial precursors also at the
midbrain–R1 region.
Several down-regulated genes were associated with other
signal transduction cascades, including IGF (Igfbp5, see
above), TNF (Tnfrsf19), and WNT (Sfrp2, Drapc1, Tcf7)
pathways. At E10.5, strong Tnfrsf19 expression was detected
both in the midbrain–R1 region and in the diencephalon (Fig.
2K; Supplementary Fig.4). In Fgfr1 mutant embryos,
Tnfrsf19 expression was down-regulated in the lateral
midbrain–R1 region (Fig. 2K′, red arrows). Unexpectedly,
the domain of Tnfrsf19 -positive cells expanded in the dorsal
R1. In E10.5 wild-type mice, Sfrp2 expression was detected
in the midbrain and R1 (Fig. 2L). Strong Sfrp2 expression
was detected in the dorsal R1 whereas in the dorsal midbrain,
the expression domain was graded diminishing towards the
MHB. In the Fgfr1 mutant embryos, the amount of Sfrp2-
positive cells was decreased in the R1 (Fig. 2L′) and the
gradient in the midbrain was not clearly seen in the mutant
embryos. Drapc1 (or Apcdd1) is a novel in vivo target gene
of Wnt/β-catenin signaling pathway (Takahashi et al., 2002).
Its expression pattern shows high similarity to β-catenin
activity pattern during embryonic development (Jukkola et
al., 2004; Maretto et al., 2003). At E10.5, expression of
Drapc1 together with Tcf7 was found in the Wnt1/Otx2
positive cells close to the MHB (Figs. 2M, N; Supplementary
Fig. 5). At the same stage in the Fgfr1 mutant embryos,
Drapc1 expression was dispersed into adjacent dorsal
rhombomere 1 (Fig. 2M′, red arrow). Overall, Drapc1 and
Tcf7 expression was clearly down-regulated in the Fgfr1
mutants (Figs. 2M′, N′).
Upregulated genes show loss of expression gradients in Fgfr1
mutant embryos
We performed whole mount in situ hybridization of the
upregulated genes (Table 2) on E9.5 and E10.5 wild-type and
Fgfr1 conditional mutant embryos. No observable changes in
expression were detected in E9.5 mutants, except for follistatin
(Fst). This was due to very weak overall expression of the genes
in the midbrain and hindbrain at E9.5 (See Supplemetary Fig. 7).
In wild-type E10.5 embryos, the upregulated genes showed
mainly two main types of expression—dorsal gradients or
combined dorsal and ventral gradients.
Genes such as Vtn (Figs. 3A, A′), Wfdc1 (Figs. 3B, B′),
RgmA (Figs. 3C, C′), Math1 (Figs. 3D, D′), Dach1 (Figs. 3E,
E′) and Mab21l1 (Figs. 3F, F′) were expressed as dorsal
gradients decreasing towards the MHB in wild-type embryos
(see also Supplementary Fig. 7). In mutants, the gradients were
lost and the expression continued uniformly strong towards the
boundary. Interestingly, WAP four disulfide core domain
protein 1 (Wfdc1) codes for a growth inhibitor ps20 (Larsen
et al., 1998). Its function would suggest a role in controlling
cell cycle, proliferation and transition to postmitotic phase
which is associated with neuronal differentiation. Therefore,
the upregulation of Wfdc1 in mutants might imply that there is
excessive premature differentiation in the tectum. Wfdc1expression was restricted to the Otx2 positive cells in Fgfr1
mutants (Supplementary Fig. 6) although some Wfdc1 positive
cells in R1 was observed in the lateral boundary area (a black
arrowhead in Fig. 3B′).
Other genes, such as low-affinity NGF receptor, NGFR1 or
p75 (Figs. 3G, G′, dotted line indicates the MHB) and
homeobox gene Uncx4.1 (Figs. 3H, H′, Supplementary Fig.
7D), were detected both as dorsal and ventral gradients in R1
and midbrain, being absent near the boundary. Expression
changes showed again the loss of gradients in Fgfr1 mutants,
although the upregulation effect was less obvious in p75 in
ventral midbrain. The C. elegans homologue of the Uncx4.1
participates in VA motor neuron specification (Miller and
Niemeyer, 1995; Miller et al., 1992; White et al., 1992).
However, the role of Uncx4.1 in neuronal differentiation in
mammals and other vertebrates is unclear, since the null mutants
do not show a CNS phenotype (Leitges et al., 2000; Mansouri
et al., 2000).
The expression changes in ventral R1 were not as uniform
as in the dorsal structures and ventral midbrain. For example,
the expression of endothelin receptor type B (Ednrb) in the
ventral R1 domain, near the boundary, was surprisingly
downregulated in the mutant embryos (Figs. 3I, I′; asterisks
point to the downregulation in R1, see Supplementary Fig.
7F,). In the ventral midbrain, the Ednrb positive cells showed
an opposite effect spreading both laterally (the region
between the black arrowheads in Fig. 3I′) and towards the
MHB.
The expression of three yet uncharacterized genes or ESTs
(Expressed Sequence Tags), found in the microarray screen,
were also validated using in situ hybridization. Sequence
analysis of NM_028263 (Affymetrix probe ID 166871_at;
UniProt Q7TNS6) found an FGF-binding protein (FGF-bp)
domain, suggesting that the gene belonged to the FGF-bp
family. FGF-bps are secreted molecules that mobilize FGFs
from the extracellular matrix and enhance their activity,
probably by presenting them to FGF-receptors (Tassi et al.,
2001). In the mutant embryos, the ventral midbrain
expression of NM_028263 spread towards the boundary
(Figs. 3J, J′, see Supplementary Fig. 7M), and a globular
strong expression patch appeared in the R1 side near the
MHB (black arrowheads).
Two other uncharacterized genes, NM_177100 (Affymetrix
probe ID 139205_at; UniProt Q8BH22) and an ESTcorresponding
to GeneBank accession BM932503 (Affymetrix probe ID
137358_at) were expressed widely in the developing CNS. In
Fgfr1mutants, the expression gradients in both tectum and ventral
midbrain were lost in NM_177100 (Figs. 3K, K′, see also
Supplementary Fig. 7L). Similar changeswere seen in the ESTwith
ID 137358_at, although it showed less obvious changes in ventral
midbrain (Figs. 3L, L′, see also Supplementary Fig. 7K).
Follistatin (Figs. 3M, M′, N, N′, see also Supplementary Fig.
7A) binds and inactivates several members of the TGF-β
superfamily of proteins, such as activin and BMP-4. In the
Fgfr1 mutants at E9.5, R1 expression domain spread almost to
the MHB and its rostral part was diffuse (compare to the gap in
expression in Fig. 3M, marked by brackets, see also
Fig. 3. Expression patterns of the upregulated genes detected by the microarray screen. Whole mount in situ hybridizations of E9.5 (M) and E10.5 (A–L, N) wild-type
(A–N) and En1-Cre/+;FgfrFlox/Flox embryos (A′–N′) with the probes indicated. Lateral views of the whole-mount-stained embryos, anterior rightwards. The MHB is
indicated with a white arrowhead and a dotted line. Brackets, asterisks and black arrowheads point to alterations in gene expression. Embryos in panels I and N have
been sagittally bisected after staining.
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Fig. 4. Analysis of neurogenesis in follistatin null mutant embryos. Whole
mount in situ hybridizations of E10.5 (A, B) embryos with the probes indicated.
Embryos in panel A have been sagittally cut after staining. Immunohistochem-
istry on E14.5 sagittal paraffin sections, anterior rightwards (C–E). TH-staining
in panels C and D, 5-HT staining in panel E. Wild-type embryos in A–E;
follistatin knock-out embryos in A′–E′. lc, locus coeruleus; III, third cranial
ganglion; IV, fourth cranial ganglion.
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in E10.5 mutant mice, where the whole R1 expressed Fst
(Fig. 3N′). Near the boundary, the expression also extended
ventrally in the mutants.
In summary, several upregulated genes showed marked
similarity in their expression patterns in E10.5 embryos. Most
of them were expressed as gradients decreasing towards MHB,
both in midbrain and rhombomere 1. In Fgfr1 mutant embryos,
these gradients disappeared both in dorsal and in ventral
regions.
Role of Fst in neuronal development in the
midbrain–hindbrain region
To analyze the role of follistatin on neurogenesis, the
expression of Phox2a (Figs. 4A, A′) and Ngn2 (Figs. 4B, B′)
were analyzed on E10.5 follistatin knock-out embryos
(Matzuk et al., 1995). If Fst normally regulates the BMP
signals from the roof plate and this way affected the
positioning of LC, we would expect to see a shift in the
position of LC. However, the expression of both genes in
mutants was identical to the wild-type controls and no changes
in LC was seen at this stage. There were no observable
changes in the appearance of locus coeruleus (Figs. 4C, C′),
midbrain dopaminergic neurons (Figs. 4D, D′) or serotonergic
neurons (Figs. 4E, E′) in E14.5 follistatin mutant embryos
either, as shown in immunohistochemistry experiments. This
suggests that the upregulation of Fst would not lead to notable
changes in neurogenesis, either.
Neuronal progenitor cell populations are affected in Fgfr1
mutant embryos
Neural precursors near the MHB differentiate later in
development, and their premature differentiation is prevented
by Hes3. The expression gradients diminishing towards the
MHB in the wild-type embryos would, in this light, indicate that
these genes are expressed in more fate-restricted and/or
differentiating cells. The loss of the expression gradients
suggests that the region of less differentiated neurons became
narrower in Fgfr1 mutants and that differentiation proceeded
prematurely towards the boundary on both sides. In Ednrb,
however, an opposite effect was seen—downregulation of
expression in ventral R1 near the boundary in mutants. The
Ednrb-positive cells in ventral R1 seem to respond differently to
the loss of FGF signaling at the IsO. This may correlate with
impaired differentiation of the serotonergic neurons in Fgfr1
mutants (see below).
Since our results suggested loss of neuronal differentiation
gradients in Fgfr1 mutants, we wanted to know what effects
would FGFR1 inactivation have on different subsets of neuronal
progenitor cells in the mid- and hindbrain. We analyzed several
genes which are known to be expressed in different neuronal
progenitors at certain stages of development.
Hes3 is a bHLH transcriptional factor and a known Notch
effector. In E10.5 Fgfr1 mutant embryos, the expression of
Hes3 is downregulated but is still weakly detectable in the
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B, B′). The loss of Hes3 expression supports the results
obtained from the upregulated genes, which suggested that
neuronal differentiation was shifted towards the MHB region
in Fgfr1 mutant embryos.In wild type embryos, a gap of mature neurons was evident
near the MHB region, as seen in Tuj1 staining (Figs. 5C, C′). In
Fgfr1 mutants the gap disappeared, although fewer Tuj1
positive cells were still detected close to the MHB compared
to more distal regions. In tectum, no differences were seen (data
not shown).
Neurogenin2 (Figs. 5D, D′, E, E′) is a basic-helix–loop–
helix (bHLH) transcriptional regulator, which functions as a
neuronal determination factor (Sommer et al., 1996). In the
Fgfr1 conditional mutant embryos, the Ngn2 expressing cell
populations of the ventral midbrain and hindbrain are less
compact and have spread towards the boundary. Especially a
strongly expressing cell population near the MHB in ventral
R1 (marked with an asterisk in Figs. 5E, E′) shows an
extensive scattering effect. Also locus coeruleus (LC) in E10.5
mutants seems less compact as compared to the wild-type. At
E11.5, the expression of Ngn2 in the dorsal R1 cells was
shifted rostrally in the mutant embryos (compare to the area
indicated with a bracket in Fig. 5E). These results are
supported by the expression analysis of a homeobox
transcription factor Phox2a, which is expressed in the
developing LC and in the oculomotoric (III) and trochlear
(IV) nuclei (Figs. 5F, F′). The III and IV cranial ganglia are the
same size in the Fgfr1 mutants as in the wild-type embryos.
However, they appear to be closer together, presumably as a
result of the loss of the boundary cell population between mid-
and hindbrain.
III and IV cranial ganglia as well as LC develop earlier
compared to other neuronal populations, such as SA or DA
neurons, in the area. They can be detected already in E9
embryos, which suggest that their development is less
dependent on the isthmic signaling and that the major events
concerning their formation takes place before the need for
FGFR1 function. This would explain their mild phenotype in
Fgfr1 conditional mutant adults—III and IV ganglia appear
normal, and LC is somewhat disorganized (Trokovic et al.,
2003).
Midbrain dopaminergic neuron progenitor pool spreads in
Fgfr1 mutants
Since several genes were upregulated in the ventral
midbrain, we examined what happens to the dopaminergic
neuron progenitors in the area. For this, we analyzed the
expression of several genes known to be involved in the earlyFig. 5. Expression patterns of genes regulating neuronal development. Whole
mount in situ hybridization analysis (A, B, D–F) with the probes and embryonic
stages indicated. Immunohistochemistry on sagittal paraffin sections with Tuj1-
antibody in C, close-up view of the ventral midbrain and R1. Wild-type embryos
in A–E and En1-Cre/+;Fgfr1Flox/Flox embryos in A′–E′. Embryos in panel A
have been cut after staining and sections are depicted in panel B. White lines
indicate cutting planes. Lateral views of the whole-mount-stained embryos,
anterior rightwards. Awhite open arrowhead indicates the MHB in panels A, D–
F and a black arrowhead in panel B. Asterisks and brackets point to altered gene
expression. E11.5 embryos have been sagittally bisected at the midline after
staining. Lc, locus coeruleus; III, oculomotoric nucleus; III, trochlear nucleus;
mb, midbrain; r1, rhombomere 1. Scale bars, 100 μm.
Fig. 6. Midbrain dopaminergic neurons in Fgfr1 mutant embryos. Whole mount (A–D) and radioactive (E, F) in situ hybridization analysis with the probes and
embryonic stages indicated. Lateral views of the embryos, anterior rightwards (A) white open arrowhead indicates the midbrain–hindbrain boundary in panels A–D.
Black arrowheads point to altered gene expression. Ventral brain morphology has been visualized with a red broken line in panels B and D. All embryos have been
sagittally bisected at the midline after staining. Tyrosine hydroxylase immunohistochemistry on paraffin sections in panel G. Sagittal views, anterior rightwards.
Orange broken line indicates the quantification area and white arrowheads point to altered TH expression. Wild-type embryos in A–E and G, En1-Cre/+;Fgfr1Flox/Flox
embryos in A′–E′, F and F′ and in G′. Quantification results in H. DA-all, total number of DA neurons; DA-C, number of DA neurons in caudal sector; DA-R, number
of DA neurons in rostral sector; c, caudal sector; r, rostral sector.
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E15.5 embryos.
In E11.5 Fgfr1 mutant embryos, the expression of Nurr1
(Figs. 6A, A′), Pitx3 (Figs. 6B, B′) and Aldh1 (also known as
Aldh1a1 and Raldh1) (Figs. 6C, C′, D, D′) spread posteriorly
(black arrowheads). The spreading of Aldh1 expression was
detected already at E10.5. The spreading of Aldh1 follows the
caudal shift in the expression of Otx2 (Figs. 6F, F′).
We next analyzed the tyrosine hydroxylase (TH) positive
dopaminergic neurons of the ventral tegmental area and
substantia nigra E15.5 wild-type and Fgfr1 mutant embryos(Fig. 6G, G′). The comparison between the total number of
dopaminergic neurons showed no statistically significant
difference between wild-type and mutant embryos (Fig.
6H). The neurons were divided into caudal and rostral
sectors (marked with an orange broken line in Figs. 6G, G′)
using the mesencephalic flexure as a landmark, and the
sectors were compared individually. The analysis revealed an
increase in the caudal sector and conversely a decrease in the
rostral sector of dopaminergic neurons in the Fgfr1 mutant
embryos. Thus, consistent with changes in gene expression
patterns, TH immunostaining at E15.5 stage revealed a caudal
Fig. 7. Rostral serotonergic neurons in Fgfr1 mutant embryos. Whole mount in situ hybridization analysis (A–E) with the probes and embryonic stages indicated. A
white open arrowhead indicates the midbrain–hindbrain boundary. Lateral views of the whole-mount-stained embryos, anterior rightwards. Black arrowheads point to
altered gene expression. Ventral brain morphology has been visualized with a red broken line in D and D′. All embryos have been sagittally bisected at the midline after
staining. Anti-5-HT immunohistochemistry on paraffin E15.5 sections (F, F′, F″). Sagittal sections, anterior rightwards. Orange broken line indicates the quantification
area, white arrows mark the caudalOtx2 expression boundary. Asterisks point to altered 5-HT expression. Quantification results in G. Radioactive in situ hybridisation
on P0 stage coronal sections with the probes indicated. Bright-field images in panel H, dark-field images in panels I and J.Wild-type embryos in A–F andH–J, En1-Cre/
+;Fgfr1Flox/Flox embryos in A′–F′ and H′–J′. SA-all, total number of SA neurons; SA-D; number of SA neurons in the dorsal population; SA-V, number of SA neurons
in the caudal population; d, dorsal population; v, ventral population.
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6G, G′, compare the area between white arrows). It seems
that although the area where the DA neurons are located
expands in mutants, the total number of these neurons does
not change. The caudal shift is probably due to the caudal
spreading of Otx2 expression (Figs. 6G and G′). In ventral
midbrain, Otx2 expression is scattered in Fgfr1 mutants at
E15.5, and the boundary between Otx2 positive and negative
areas is less obvious than in the wild-type. This wouldsuggest that the mixing of ventral midbrain and R1 cells
forms a tissue mosaic in the Fgfr1 mutants (see below).
The most rostral serotonergic neuron precursors are lost in
Fgfr1 mutant embryos
FGF8 from the IsO is thought to be one of the major signals
guiding the development of serotonergic neurons in the raphe
nuclei (Ye et al., 1998). To find out whether serotonergic
Fig. 8. Schematic illustration of midbrain and anterior rhombomere 1 neuronal
cell populations and summarizing gene expression patterns of FGF regulated
genes at the MHB region. Lateral views of E10.5 wild-type (A and B) and Fgfr1
mutant (A′ and B′) embryos. Gene expression changes in Fgfr1mutant embryos
(A′) compared with wild-type (A). A narrow slowly proliferating cell population
was lost in Fgfr1 mutants (yellow line in A). In addition, the loss of Fgfr1
activity lead to downregulation of several genes expressed at the posterior
midbrain and anterior R1 (A and A′). The expression patterns of these genes are
marked with a green hatching (A and A′). Red dotted areas represents a pattern
of genes that showed gradient-like expression both in the midbrain and R1 and
were found to be downregulated in the midbrain–R1 region in the Fgfr1mutants
(A and A′). By contrast, orange gradients show a pattern for upregulated genes
(A and A′). Neuronal progenitor populations at the midbrain–R1 region are
marked as indicated with boxes (B and B′). Black arrows represent the direction
of a shift in the neuron-specific gene expressions (B). Arrowheads and broken
lines mark the MHB. mb, midbrain; r1, rhombomere 1; DA, dopaminergic
neurons; LC, locus coeruleus; SA, serotonergic neurons.
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expression patterns of several genes that are known to be
involved in the SA neuron specification and quantified the
rostral serotonergic neurons in E15.5 embryos.
In Fgfr1 mutants, several genes which are involved in the
specification of serotonergic neurons, such as zinc-finger
transcription factor Gata3 (Figs. 7A, A′) a bHLH transcription
factorMash1/Ascl1 (Figs. 7B, B′) and Pet1 (Figs. 7D, D′, F, F′),
were downregulated near the MHB region in ventral R1 (black
arrowheads). The expression ofMash1 and Gata3 in the ventral
midbrain showed, however, an opposite effect, spreading
strongly towards the boundary. This is consistent with posterior
expansion in the expression of DA neuron specification genes.
The rostral Pet1 expression boundary is narrower and
disorganized compared to the wild-type controls. This result
combined with the downregulation of upstream effectorsMash1
and Gata3 would directly imply that the rostralmost population
of raphe nuclei does not develop in conditional Fgfr1 mutants.
Double in situ hybridization with midbrain specific Otx2 and
Mash1 shows that at E10.5,Mash1 downregulation in R1 is not
only due to Otx2 spreading into R1 area (Figs. 7C, C′).
However, at E11.5 Otx2 extensively spreads into ventral R1 and
masks Pet1 downregulation (Figs. 7E, E′).
We performed anti-5HT immunohistochemistry on E15.5
sagittal sections to characterize whether downregulation of the
transcription factors has an effect on SA neuron development.
5-HT could be seen in a large area extending to the top of the
mesencephalic flexure in the wild-type embryos (Fig. 7F). In
Fgfr1 mutants, the rostral boundary of SA neuron population
was shifted caudally and less 5-HT positive neurons were
seen near the top of the flexure (compare the area marked
with asterisks in Figs. 7F, F′, F″). The caudal shift of Otx2
expression in mutants (caudal expression boundary of Otx2 is
indicated with a white arrowhead in panel F) did not
completely prevent rostral SA neuron development. The SA
neurons located more caudally seemed unaffected in mutants.
We quantified the serotonergic neurons in rostral R1 at E15.5
wild-type and Fgfr1 mutant embryos (the quantified area is
depicted with an orange broken line in Figs. 7F, F′, F″). When
the total number of neurons was compared, their number was
significantly decreased in mutants (Fig. 7G). The neurons were
divided into dorsal and ventral populations which were
compared individually. The loss of the most rostral SA neurons
explains the decrease in the dorsal population. The ventral
population seems to be unaffected in Fgfr1 mutants. The
quantification results reflect the changes in early gene
expression, where the downregulation was seen in the rostral
area only. Results from P0 stage support these observations. Sert
is downregulated and diffuse in mutants (Figs. 7H, H′, I, I′).
Interestingly, consistent with the expression of Phox2a at E10.5,
the development of the trochlear nucleus appears normal in
mutants (Figs. 7J, J′).
It is interesting that the downregulation of transcription
factors Mash1, Gata3 and Pet1 could be seen only in the
vicinity of the boundary. The early downregulation of the
proneural geneMash1 suggests that the SA progenitors near the
MHB require a high dose of FGF-signals from IsO in order todevelop normally. In the explant culture experiments, FGF4 in
combination with FGF8 and SHH could induce SA neuron
development (Ye et al., 1998). However, FGF4 itself is not
expressed in the vicinity of developing rostral SA neurons at
E10.5–11.5. Since FGFR1 is inactivated by 10 somite stage
(Trokovic et al., 2003), the early FGF4 signaling functions
normally in Fgfr1 mutants. This suggests that other FGFs from
the IsO are the major regulators in SA neuron development. It is
possible that in the explant culture experiments FGF4 mimicked
the high FGF signaling activity near the MHB, which is
normally achieved by the combination of FGFs expressed by
the IsO. In Fgfr1 mutants, the amount of activating IsO signals
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developmental pathway is impaired. Serotonergic neurons
further away from the boundary express normally all the
genes in the SA pathway, as well as 5-HT, and seem less
dependent on the isthmic signaling.
Conclusions
A proposed model on the role of FGF-signaling from the
isthmic organizer in regulating neurogenesis in the midbrain and
R1 of the hindbrain is shown in Fig. 8. Our screen identified
several genes responsible for cell cycle regulation, which were
downregulated in Fgfr1 mutant embryos. They can be grouped
into three classes based on their response to FGF signaling
through FGFR1 in the midbrain–R1. First, Flrt3, Trh, Mrp4,
Igfbp5 and Jmj are expressed in narrow bands near the MHB.
They are completely abolished in the Fgfr1mutants (Figs. 8A, A
′). Second, a group of genes expressed in a broader domain such
as Hes3 which maintain the expression of IsO-specific genes
(e.g., Fgf8 and Pax5) and inhibit neuronal differentiation (Fig.
8A). Expression of also these genes requires FGFR1, except for
the most ventral region where a small domain of ventral
expression remains possibly due to the expression of Fgfr2 and
Fgfr3 ventrally (Fig. 8A′). Third, cell cycle regulators CyclinD2
and Sox3 are expressed throughout the midbrain–R1 region
being absent close to the MHB (Fig. 8A). In the Fgfr1 mutants,
CyclinD2- and Sox3-negative domains were abolished, but the
overall expression levels were decreased at the midbrain–R1
region (Fig. 8A′). The downregulation of cell cycle activators in
the midbrain and R1 of the Fgfr1 mutants would indicate that
cell proliferation in the region was decreased. The disappearance
of Hes3-domain might lead to premature neuronal differentia-
tion in the midbrain–R1 region.
The data from the upregulated genes supported the
deregulation of cell differentiation in the area, as expression
analysis showed disappearance of gene expression gradients in
tectum as well as in the ventral midbrain/R1 (Figs. 8A, A′).
There are genes (e.g., Vtn, Wfdc1 and Fst) expressed in the
anterior midbrain, expression of which expanded posteriorly in
the Fgfr1 mutants. Other genes (e.g., Math1, Uncx4.1, Fst and
Ednrb) were expressed in the posterior R1 and their expression
shifted anteriorly in the midbrain mutants. However, various
neuronal populations differ in their requirement for FGF
signaling through FGFR1. Whereas the midbrain dopaminergic
neurons shift posteriorly but their numbers are largely
unaffected, the rostral serotonergic neurons are greatly reduced
in Fgfr1 mutants. Thus, high signaling levels are required for
the proper development of the rostral SA neurons in R1. Our
model suggests that high FGF-signaling levels from the IsO
prevent neuronal differentiation in the midbrain side near the
MHB. When FGF-signaling from IsO is abolished in Fgfr1
mutants, neurogenesis can proceed closer to MHB in the
midbrain but is impaired in the ventral R1. In zebrafish Ace
mutants, R1 is rostralized into midbrain in the absence of
isthmic Fgf8 signaling (Jaszai et al., 2003). However, in Fgfr1
mutants, instead of complete fate transformation extensive
mixing of ventral midbrain cells into R1 is detected.Acknowledgments
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